Cargando…

Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)

BACKGROUND: The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for psychosomatic disorder patients has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriguchi, Yoshiya, Maeda, Motonari, Igarashi, Tetsuya, Ishikawa, Toshio, Shoji, Masayasu, Kubo, Chiharu, Komaki, Gen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838425/
https://www.ncbi.nlm.nih.gov/pubmed/17371586
http://dx.doi.org/10.1186/1751-0759-1-7
_version_ 1782132828117401600
author Moriguchi, Yoshiya
Maeda, Motonari
Igarashi, Tetsuya
Ishikawa, Toshio
Shoji, Masayasu
Kubo, Chiharu
Komaki, Gen
author_facet Moriguchi, Yoshiya
Maeda, Motonari
Igarashi, Tetsuya
Ishikawa, Toshio
Shoji, Masayasu
Kubo, Chiharu
Komaki, Gen
author_sort Moriguchi, Yoshiya
collection PubMed
description BACKGROUND: The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for psychosomatic disorder patients has not been adequately investigated. Although alexithymia most likely has certain developmental aspects, this has infrequently been investigated. METHODS: The newly-developed Japanese TAS-20 was administered to a normative sample (n = 2,718; 14–84 y.o.), along with the NEO Five-Factor Inventory (NEO-FFI) for cross validation. Psychosomatic patients (n = 1,924, 12–87 y.o.) were tested to evaluate the factor structure in a clinical sample. College students (n = 196) were used for a test-retest study. Internal reliability and consistency were assessed, and the factorial structure was evaluated using confirmatory and exploratory factor analyses for both the normative and the clinical samples. The correlations between the TAS-20 and the NEO-FFI factor scores were evaluated. Age-related and gender differences in the TAS-20 were explored using analysis of variance in the normative sample. RESULTS: The original three-factor model of the TAS-20 was confirmed to be valid for these Japanese samples, although a 4-factor solution that included negatively keyed items (NKI) as an additional factor was more effective. Significant correlations of the TAS-20 with the NEO-FFI were found, as has been previously reported. Factor analyses of the normative and patient samples showed similar patterns. The TAS-20 total, difficulty in identifying feelings (DIF), and difficulty in describing feelings (DDF) scores were high for teenagers, decreased with age, and from 30s did not change significantly. In contrast, externally oriented thinking (EOT) scores showed an almost linear positive correlation with age. DIF scores were higher for females, while EOT scores were higher for males, without any interaction between gender and age differences. CONCLUSION: The original three-factor concept of the TAS-20 was generally supported for practical use. Age-related differences in TAS-20 scores indicate developmental aspects of alexithymia. Alexithymia is made up of two components with different developmental paths: DIF/DDF and EOT.
format Text
id pubmed-1838425
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18384252007-03-28 Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20) Moriguchi, Yoshiya Maeda, Motonari Igarashi, Tetsuya Ishikawa, Toshio Shoji, Masayasu Kubo, Chiharu Komaki, Gen Biopsychosoc Med Research BACKGROUND: The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for psychosomatic disorder patients has not been adequately investigated. Although alexithymia most likely has certain developmental aspects, this has infrequently been investigated. METHODS: The newly-developed Japanese TAS-20 was administered to a normative sample (n = 2,718; 14–84 y.o.), along with the NEO Five-Factor Inventory (NEO-FFI) for cross validation. Psychosomatic patients (n = 1,924, 12–87 y.o.) were tested to evaluate the factor structure in a clinical sample. College students (n = 196) were used for a test-retest study. Internal reliability and consistency were assessed, and the factorial structure was evaluated using confirmatory and exploratory factor analyses for both the normative and the clinical samples. The correlations between the TAS-20 and the NEO-FFI factor scores were evaluated. Age-related and gender differences in the TAS-20 were explored using analysis of variance in the normative sample. RESULTS: The original three-factor model of the TAS-20 was confirmed to be valid for these Japanese samples, although a 4-factor solution that included negatively keyed items (NKI) as an additional factor was more effective. Significant correlations of the TAS-20 with the NEO-FFI were found, as has been previously reported. Factor analyses of the normative and patient samples showed similar patterns. The TAS-20 total, difficulty in identifying feelings (DIF), and difficulty in describing feelings (DDF) scores were high for teenagers, decreased with age, and from 30s did not change significantly. In contrast, externally oriented thinking (EOT) scores showed an almost linear positive correlation with age. DIF scores were higher for females, while EOT scores were higher for males, without any interaction between gender and age differences. CONCLUSION: The original three-factor concept of the TAS-20 was generally supported for practical use. Age-related differences in TAS-20 scores indicate developmental aspects of alexithymia. Alexithymia is made up of two components with different developmental paths: DIF/DDF and EOT. BioMed Central 2007-03-06 /pmc/articles/PMC1838425/ /pubmed/17371586 http://dx.doi.org/10.1186/1751-0759-1-7 Text en Copyright © 2007 Moriguchi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Moriguchi, Yoshiya
Maeda, Motonari
Igarashi, Tetsuya
Ishikawa, Toshio
Shoji, Masayasu
Kubo, Chiharu
Komaki, Gen
Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)
title Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)
title_full Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)
title_fullStr Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)
title_full_unstemmed Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)
title_short Age and gender effect on alexithymia in large, Japanese community and clinical samples: a cross-validation study of the Toronto Alexithymia Scale (TAS-20)
title_sort age and gender effect on alexithymia in large, japanese community and clinical samples: a cross-validation study of the toronto alexithymia scale (tas-20)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838425/
https://www.ncbi.nlm.nih.gov/pubmed/17371586
http://dx.doi.org/10.1186/1751-0759-1-7
work_keys_str_mv AT moriguchiyoshiya ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20
AT maedamotonari ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20
AT igarashitetsuya ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20
AT ishikawatoshio ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20
AT shojimasayasu ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20
AT kubochiharu ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20
AT komakigen ageandgendereffectonalexithymiainlargejapanesecommunityandclinicalsamplesacrossvalidationstudyofthetorontoalexithymiascaletas20